Consistency Assessment of Regional Treatment Effect for Multi-Regional Clinical Trials in the Presence of Covariate Shift

2026-02-07

AI Summary

This study addresses the challenge of covariate shift—differences in baseline covariate distributions across regions—in multiregional clinical trials, which can bias regional treatment effect estimates and compromise assessments of efficacy consistency. To mitigate this issue, the authors propose a two-stage evaluation strategy that, for the first time in consistency analysis, incorporates a causal inference framework to model the conditional average treatment effect (CATE), explicitly adjusting for covariate shift. This approach supersedes conventional methods that rely solely on marginal treatment effects. Extensive numerical simulations demonstrate that the proposed method substantially reduces estimation bias and significantly enhances both the accuracy and robustness of evaluating treatment effect consistency across regions.

Technology Category

• Machine Learning: Causal Learning
• Reasoning under Uncertainty: Causality
• Constraint Satisfaction and Optimization: Distributed CSP/Optimization

Application Category

• User Modeling, Personalization and Recommendation: Fairness-aware retrieval and ranking
• Search and Retrieval-Augmented AI: Web evaluation methodologies and metrics
• Security and Privacy: Large-scale security measurements

Abstract

Multi-Regional Clinical Trials (MRCTs) play a central role in the development of new therapies by enabling the simultaneous evaluation of drug efficacy and safety across diverse global populations. Assessing the consistency of treatment effects across regions is a fundamental aspect of MRCTs. Existing methods typically focus on region-specific marginal treatment effects. However, when treatment effect heterogeneity arises due to effect-modifying baseline covariates, distributional differences in these covariates can lead to erroneous conclusions. In this paper, we explicitly account for this phenomenon in the consistency assessment by considering the conditional average treatment effect. We propose a two-step assessment strategy that complements existing methods and mitigates the impact of treatment effect heterogeneity. Results from numerical studies demonstrate the effectiveness of the proposed approach.

Problem

• Multi-Regional Clinical Trials
• Treatment Effect Consistency
• Covariate Shift
• Effect Modification
• Conditional Average Treatment Effect

Innovation

• conditional average treatment effect
• covariate shift
• multi-regional clinical trials
• treatment effect heterogeneity
• consistency assessment